InVivoMab anti-mouse Ly6C BE0203-R001mg from Bio X Cell | Biocompare.com

Supplier Images

InVivoMab anti-mouse Ly6C

Be the first to write a review!

Citations:

Supplier Page from
Bio X Cell for
InVivoMab anti-mouse Ly6C

The InVivoMab anti-mouse Ly6C Antibody from Bio X Cell is a Rat Monoclonal antibody to Ly6c1. This antibody recognizes Mouse antigen. The InVivoMab anti-mouse Ly6C Antibody has been validated for the following applications: Removal, In Vivo, and Flow Cytometry.

Description

Bio X Cell InVivoMAb anti-mouse Ly6C Monoclonal Antibody has the following reported applications: in vivo macrophage depletion (in combination with clodronate liposomes), Flow cytometry. It features greater than 95% purity, ultra-low endotoxin levels, and are preservative, stabilizer, and carrier protein-free

Product Specs
ItemInVivoMab anti-mouse Ly6C
CompanyBio X Cell
Price Pricing Info Supplier Page View Company Product Page
Catalog NumberBE0203-R001mg
Quantity1 mg
Applicationsin vivo macrophage depletion (in combination with clodronate liposomes), Flow cytometry
ConcentrationLot specific,typically between 4-11 mg/ml
Conjugate/TagUnconjugated
ReactivityMouse
TargetLy6C
IsotypeIgG2a
CloneMonts 1
Hostrat
NCBI Full Gene Namelymphocyte antigen 6 family member C1
NCBI Gene AliasesLy-6C, Ly-6C1, Ly6c
ClonalityMonoclonal
Antibody TypePrimary Antibody
Purity>95%, Determined by SDS-PAGE
FormatPBS, pH 7.0, Contains no stabilizers or preservatives
Research AreaImmunology, Innate Immunity

Specifications/Features

Other available quantities: Available in 1, 5, 10, 25, 50, 100 mg and bulk sizes. Academic discount available.

Endotoxin: <2EU/mg (<0.002EU/µg), Determined by LAL gel clotting assay

Add to Compare List

Bio X Cell

Bio X Cell

39 Labombard Rd

Lebanon, NH 03766

United States

Phone: 1-866-787-3444

Email: customerservice@bxcell.com

Company Profile

Website: bioxcell.com

(1) Subclinical Herpes Simplex Virus Type 1 Infections Provide Site-Specific Resistance to an Unrelated PathogenJournal of immunology (Baltimore, Md. : 1950)February 15, 2017Rowe AM, Yun H, Treat BR, Kinchington PR, Hendricks RL.

(2) Selective blockade of herpesvirus entry mediator-B and T lymphocyte attenuator pathway ameliorates acute graft-versus-host reactionJournal of immunology (Baltimore, Md. : 1950)May 15, 2012del Rio ML, Jones ND, Buhler L, Norris P, Shintani Y, Ware CF, Rodriguez-Barbosa JI.

(3) Securinine, a GABAA receptor antagonist, enhances macrophage clearance of phase II C. burnetii: comparison with TLR agonistsJournal of leukocyte biologyNovember 1, 2007Lubick K, Radke M, Jutila M.

(4) Distinction of class II MHC+ Langerhans cell-like interstitial dendritic antigen-presenting cells in murine dermis from dermal macrophagesThe Journal of investigative dermatologyNovember 1, 1994Duraiswamy N, Tse Y, Hammerberg C, Kang S, Cooper KD.

(5) Ly-6C is a monocyte/macrophage and endothelial cell differentiation antigen regulated by interferon-gammaEuropean journal of immunologyNovember 1, 1988Jutila MA, Kroese FG, Jutila KL, Stall AM, Fiering S, Herzenberg LA, Berg EL, Butcher EC.

Be the First to Write a Review!